Event date:
|
February 9, 2012
|
City
|
• Overview of Indian healthcare and clinical trial system towards 2013
• Discovering the new trends in global clinical trials and their role in India
• Strategies to conduct successful interventional oncology trials in India
• What are the expectations of regulatory authorities and what type of regulatory structure does India currently have?
• Overcoming challenges faced in regulatory approval processes – obtaining drug/ clinical supplies import and export licenses in Asia
• Regulatory review at the Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organization (CDSCO): science, quality, and speed
• Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO
• How to achieve open and effective outsourcing partnerships
• How to Identify smart packaging solutions to balance quality and costs
• Identifying the decision criteria for partnering with the right vendors in Asia
• Identifying the main challenges to secure and increase global drug supply in the public sector
• How to manage risks in clinical trials effectively and how to successfully incorporate risk sharing models in clinical trials
• Extended Information for accelerating patient recruitment & retention in clinical trials.
• Finding the right clinical trial supply chain model to optimize the costs
• How to avoid mistakes in data collection and ensuring profitability and to understand the long term operation strategies for managing clinical trials.
• Understanding new e-clinical technologies to improve data quality and optimise clinical outcomes
• Next generation of clinical trials – How big will the market be?
For more details: Click Here
No comments:
Post a Comment